Summit Partners Public Asset Management »

Moonlake Immunot shares owned by Summit Partners Public Asset Management

Quarter-by-quarter ownership of Moonlake Immunot (MLTX) shares owned by Summit Partners Public Asset Management from 13F filings

Historical chart of Summit Partners Public Asset Management investment in Moonlake Immunot

Tip: Access up to 7 years of quarterly data

All positions including Moonlake Immunot held by Summit Partners Public Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moonlake Immunot by Summit Partners Public Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $717k 100k 7.17

More positions owned by Summit Partners Public Asset Management

Spotify Technology S A SHS (SPOT)
Insmed Com Par $.01 Call Option (INSM)
Verona Pharma Sponsored Ads (VRNA)
NVIDIA Corporation Call Option (NVDA)
Sandisk Corp (SNDK)
Ge Vernova (GEV)
Microsoft Corporation (MSFT)
Carvana Cl A Call Option (CVNA)
Solaris Energy Infras Com Cl A Put Option (SEI)
Mongodb Cl A Put Option (MDB)
Rubrik Cl A (RBRK)
Genedx Holdings Corp Com Cl A (WGS)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
MKS Instruments Call Option (MKSI)
Astera Labs (ALAB)

View all positions for Summit Partners Public Asset Management

Top funds holding Moonlake Immunot

BVF
venBio Select Advisor
Cormorant Asset Management
Balyasny Asset Management
Adage Capital Partners GP
Ikarian Capital
Schonfeld Strategic Advisors
Susquehanna International
Jane Street
Boothbay Fund Management
Caption Management
FMR
Nuveen
Citadel Advisors
Two Sigma Investments

View all funds holding Moonlake Immunot